Literature DB >> 22018935

A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.

James R Hébert1, Thomas G Hurley, Brook E Harmon, Sue Heiney, Christine J Hebert, Susan E Steck.   

Abstract

BACKGROUND: Nearly 35% of men treated for prostate cancer (PrCA) will experience biochemically defined recurrence, noted by a rise in PSA, within 10 years of definitive therapy. Diet, physical activity, and stress reduction may affect tumor promotion and disease progression.
METHODS: A randomized trial of an intensive diet, physical activity, and meditation intervention was conducted in men with rising post-treatment PSA after definitive treatment for PrCA. Intention-to-treat methods were used to compare usual care to the intervention in 47 men with complete data. Signal detection methods were used to identify dietary factors associated with PSA change.
RESULTS: The intervention and control groups did not differ statistically on any demographic or disease-related factor. Although the intervention group experienced decreases of 39% in intakes of saturated fatty acid (SFA as percent of total calories) (p<0.0001) and 12% in total energy intake (218 kcal/day, p<0.05)], no difference in PSA change was observed by intervention status. Signal detection methods indicated that in men increasing their consumption of fruit, 56% experienced no rise in PSA (vs. 29% in men who did not increase their fruit intake). Among men who increased fruit and fiber intakes, PSA increased in 83% of participants who also increased saturated fatty acid intake (vs. 44% in participants who decreased or maintained saturated fatty acid intake).
CONCLUSION: Results are discussed in the context of conventional treatment strategies that were more aggressive when this study was being conducted in the mid-2000s. Positive health changes in a number of lifestyle parameters were observed with the intervention, and both increased fruit and reduced saturated fat intakes were associated with maintaining PSA levels in men with biochemically recurrent disease. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018935      PMCID: PMC3267863          DOI: 10.1016/j.canep.2011.09.008

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  79 in total

1.  Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.

Authors:  Anthony V D'Amico
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

2.  Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer?

Authors:  G A Saxe; J R Hébert; J F Carmody; J Kabat-Zinn; P H Rosenzweig; D Jarzobski; G W Reed; R D Blute
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

Review 3.  The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

Authors:  Elizabeth A Platz; Edward Giovannucci
Journal:  J Steroid Biochem Mol Biol       Date:  2005-01-05       Impact factor: 4.292

4.  Combined impact of lifestyle factors on cancer mortality in men.

Authors:  Chong-Do Lee; Xuemei Sui; Steven P Hooker; James R Hébert; Steven N Blair
Journal:  Ann Epidemiol       Date:  2011-06-16       Impact factor: 3.797

5.  Dietary intervention after definitive therapy for localized prostate cancer: results from a pilot study.

Authors:  J Kellogg Parsons; Vicky A Newman; James L Mohler; John P Pierce; Shirley Flatt; Karen Messer; James Marshall
Journal:  Can J Urol       Date:  2009-06       Impact factor: 1.344

6.  Effects of passive smoking in the Multiple Risk Factor Intervention Trial.

Authors:  K H Svendsen; L H Kuller; M J Martin; J K Ockene
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

7.  Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.

Authors:  D W West; M L Slattery; L M Robison; T K French; A W Mahoney
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

8.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats.

Authors:  K K Carroll; R L Noble
Journal:  Carcinogenesis       Date:  1987-06       Impact factor: 4.944

Review 10.  Dietary intervention in the management of prostate cancer.

Authors:  Wendy Demark-Wahnefried; Mark A Moyad; Mark M Moyad
Journal:  Curr Opin Urol       Date:  2007-05       Impact factor: 2.309

View more
  22 in total

1.  Considering the Role of Stress in Populations of High-Risk, Underserved Community Networks Program Centers.

Authors:  James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson
Journal:  Prog Community Health Partnersh       Date:  2015

2.  Perspective: Randomized Controlled Trials Are Not a Panacea for Diet-Related Research.

Authors:  James R Hébert; Edward A Frongillo; Swann A Adams; Gabrielle M Turner-McGrievy; Thomas G Hurley; Donald R Miller; Ira S Ockene
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

3.  Design and methods for "Commit to Get Fit" - a pilot study of a school-based mindfulness intervention to promote healthy diet and physical activity among adolescents.

Authors:  Elena Salmoirago-Blotcher; Sue Druker; Florence Meyer; Beth Bock; Sybil Crawford; Lori Pbert
Journal:  Contemp Clin Trials       Date:  2015-02-14       Impact factor: 2.226

4.  C-reactive protein levels in African Americans: a diet and lifestyle randomized community trial.

Authors:  James R Hébert; Michael Wirth; Lisa Davis; Briana Davis; Brook E Harmon; Thomas G Hurley; Ruby Drayton; E Angela Murphy; Nitin Shivappa; Sara Wilcox; Swann A Adams; Heather M Brandt; Christine E Blake; Cheryl A Armstead; Susan E Steck; Steven N Blair
Journal:  Am J Prev Med       Date:  2013-10       Impact factor: 5.043

5.  Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer.

Authors:  Samuel O Antwi; Susan E Steck; Hongmei Zhang; Lareissa Stumm; Jiajia Zhang; Thomas G Hurley; James R Hebert
Journal:  Cancer Epidemiol       Date:  2015-07-09       Impact factor: 2.984

6.  Scientific decision making, policy decisions, and the obesity pandemic.

Authors:  James R Hebert; David B Allison; Edward Archer; Carl J Lavie; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2013-06       Impact factor: 7.616

Review 7.  Effects of psycho-behavioral interventions on immune functioning in cancer patients: a systematic review.

Authors:  Guixian Tong; Qingqing Geng; Jing Cheng; Jing Chai; Yi Xia; Rui Feng; Lu Zhang; Debin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-14       Impact factor: 4.553

8.  Promoting Healthy Eating and Physical Activity Behaviors: A Systematic Review of Multiple Health Behavior Change Interventions Among Cancer Survivors.

Authors:  Steve Amireault; Angela J Fong; Catherine M Sabiston
Journal:  Am J Lifestyle Med       Date:  2016-08-04

Review 9.  A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality.

Authors:  Lucy E Hackshaw-McGeagh; Rachel E Perry; Verity A Leach; Sara Qandil; Mona Jeffreys; Richard M Martin; J Athene Lane
Journal:  Cancer Causes Control       Date:  2015-09-09       Impact factor: 2.506

Review 10.  Interventions for promoting habitual exercise in people living with and beyond cancer.

Authors:  Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke
Journal:  Cochrane Database Syst Rev       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.